Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Anesthesia

Therapeutic area intelligence for Anesthesia with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals
3
Catalysts
0
Companies
0

Companies

No related entities indexed yet.

Assets

Anesthesia →
Draeger →

Recent signals(3)

ClinicalJune 21, 2026

Study on Transnasal Microstream EtCO2 Monitoring in Elderly Post-Surgery Patients

A randomized controlled trial is assessing the impact of transnasal microstream EtCO₂ monitoring on hypoxemia in elderly patients post-abdominal surgery.

CompetitiveJune 20, 2026

Draeger Issues Correction for A350 and A350XL Anesthesia Machines Due to Ventilator Failure Risk

Draeger, Inc. is correcting additional anesthesia workstations due to a manufacturing error that may lead to ventilator failure.

ClinicalJune 2, 2026

Comparative Study of SPSIPB vs Thoracic Paravertebral Block for Opioid Reduction

This clinical trial aims to compare the analgesic efficacy of Serratus Posterior Superior Intercostal Plane Block and Thoracic Paravertebral Block in reducing postoperative opioid consumption after open thoracotomy.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.